Bandingkan Harga & Kinerja Bank Sinarmas Tbk (BSIM) vs Dharma Polimetal Tbk. (DRMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Sinarmas Tbk dan Dharma Polimetal Tbk.: Bank Sinarmas Tbk diperdagangkan di Rp690 (kapitalisasi pasar 13,56 T, volume 24 jam 13,7 rb), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp985 (kapitalisasi pasar 4,64 T, volume 24 jam 456 rb). Perbedaan utamanya: Bank Sinarmas Tbk jauh lebih besar — sekitar 2,9× kapitalisasi pasar Dharma Polimetal Tbk., dan Dharma Polimetal Tbk. lebih aktif diperdagangkan (456 rb vs 13,7 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BSIM | DRMA | |
|---|---|---|
Kapitalisasi Pasar | 13,56 T | 4,64 T |
Volume | 13,7 rb | 456 rb |
Lot | 137 | 4,56 rb |
Perputaran | 9,48 jt | 449,34 jt |
Harga Rata-rata | 692,04 | 985,4 |
Nilai Transaksi | 9,48 jt | 449,34 jt |
Harga Ekuilibrium Indikatif | 695 | 985 |
Volume Ekuilibrium Indikatif | 200 | 54,6 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Sinarmas Tbk
PT Bank Sinarmas (the company) was established under its original name of PT Bank Shinta Indonesia base on notarial deed No.52 of Mr Buniarti Tjandra, S.H, dated on 18 Aug, 1989. The Company’s articles of association has been amended several times, most recently by notarial deed No.31 of Sutjipto, S.H., dated Apr 6 2010, concerning among others, change in par value, the name of the company, and public offering.
Selengkapnya di halaman BSIM →Tentang Dharma Polimetal Tbk.
PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.
Selengkapnya di halaman DRMA →
